OrangeBookPatents.com Provides Free, Easy-to-use Access to Drug Patent And Exclusivity Information

Apr 25, 2001, 01:00 ET from OrangeBookPatents.com

    HILLSBOROUGH, N.J., April 25 /PRNewswire/ --  With drug prices being in
 the news, the issue of patented versus generic drugs is a subject of great
 debate.  To make it easier to see the patent and exclusivity information for
 FDA-approved drugs, Bruce Pokras, a pharmaceutical company patent attorney,
 has launched OrangeBookPatents.com.  This web site contains all of the patent
 and exclusivity information from the U.S. Food and Drug Administration's
 so-called "Orange Book" in an easy-to-use, highly hyperlinked format.
 
     What is the FDA's Orange Book?
 
     Officially titled "Approved Drug Products with Therapeutic Equivalence
 Evaluations," the Orange Book lists every drug that has been approved for use
 in humans by the FDA.  An addendum contains information about the patents and
 market exclusivities that cover some of the listed drugs.
 
     What is the OrangeBookPatents.com web site?
 
     The OrangeBookPatents.com web site (http://www.OrangeBookPatents.com)
 contains the patent and exclusivity addendum information from the Orange
 Book in easy-to-use tables that have the products arranged alphabetically by
 trademark.  The tables make it easy to see, with a single glance, all of the
 patent and exclusivity information for all the different variations of each
 drug product.
     What makes these tables even more useful are their hypertext links. Each
 New Drug Application number is linked to the detailed information for that
 product in the FDA's "Electronic Orange Book." Additionally, each patent
 number is linked directly to the full text of that patent on the U.S. Patent
 and Trademark Office's web site.  This is much easier than first getting the
 patent numbers from the Electronic Orange Book and then searching for those
 patents at the PTO site.
     In addition to free access to the files that are alphabetical by
 trademark, OrangeBookPatents.com offers reasonably priced annual subscriptions
 to an enhanced collection of files that can be made available to an
 organization's employees over its Intranet.  Subscribers may choose the full
 set of files, or may choose a company-specific set of files that only contain
 the patent and exclusivity information for the products of a single company.
 Moreover, if an annual subscription is not desired, the full set of files and
 the company-specific set of files are both available as a one-time "snapshot."
 Further information is available on the OrangeBookPatents.com web site.
 
     Contact:  Bruce Pokras of OrangeBookPatents.com, 908-281-7165, or
                bpokras@orangebookpatents.com .
 
     This release was issued through DigitalWork -- The Leader in Enabling
 eServices.  For more information visit: http://www.digitalwork.com.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X87824566
 
 

SOURCE OrangeBookPatents.com
    HILLSBOROUGH, N.J., April 25 /PRNewswire/ --  With drug prices being in
 the news, the issue of patented versus generic drugs is a subject of great
 debate.  To make it easier to see the patent and exclusivity information for
 FDA-approved drugs, Bruce Pokras, a pharmaceutical company patent attorney,
 has launched OrangeBookPatents.com.  This web site contains all of the patent
 and exclusivity information from the U.S. Food and Drug Administration's
 so-called "Orange Book" in an easy-to-use, highly hyperlinked format.
 
     What is the FDA's Orange Book?
 
     Officially titled "Approved Drug Products with Therapeutic Equivalence
 Evaluations," the Orange Book lists every drug that has been approved for use
 in humans by the FDA.  An addendum contains information about the patents and
 market exclusivities that cover some of the listed drugs.
 
     What is the OrangeBookPatents.com web site?
 
     The OrangeBookPatents.com web site (http://www.OrangeBookPatents.com)
 contains the patent and exclusivity addendum information from the Orange
 Book in easy-to-use tables that have the products arranged alphabetically by
 trademark.  The tables make it easy to see, with a single glance, all of the
 patent and exclusivity information for all the different variations of each
 drug product.
     What makes these tables even more useful are their hypertext links. Each
 New Drug Application number is linked to the detailed information for that
 product in the FDA's "Electronic Orange Book." Additionally, each patent
 number is linked directly to the full text of that patent on the U.S. Patent
 and Trademark Office's web site.  This is much easier than first getting the
 patent numbers from the Electronic Orange Book and then searching for those
 patents at the PTO site.
     In addition to free access to the files that are alphabetical by
 trademark, OrangeBookPatents.com offers reasonably priced annual subscriptions
 to an enhanced collection of files that can be made available to an
 organization's employees over its Intranet.  Subscribers may choose the full
 set of files, or may choose a company-specific set of files that only contain
 the patent and exclusivity information for the products of a single company.
 Moreover, if an annual subscription is not desired, the full set of files and
 the company-specific set of files are both available as a one-time "snapshot."
 Further information is available on the OrangeBookPatents.com web site.
 
     Contact:  Bruce Pokras of OrangeBookPatents.com, 908-281-7165, or
                bpokras@orangebookpatents.com .
 
     This release was issued through DigitalWork -- The Leader in Enabling
 eServices.  For more information visit: http://www.digitalwork.com.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X87824566
 
 SOURCE  OrangeBookPatents.com